Medical News

RSS

Quantros' application for fulfilling complex reporting requirements of MMSEA Section 111

Quantros announces the availability of MMSEA Manager, an application facilitating the online reporting of claims data required by CMS for Medicare clients who are part of a lawsuit and/or an ongoing medical payment or settlement. Testing and optional submission of MMSEA claim input files began January 1, 2010, with mandatory submission beginning April 1, 2010. The application is the latest addition to the Quantros Safety and Risk Management (SRM) product family.

12 Jan 2010

Nursing educators learn latest developments in nursing education at Faculty Development Institute conference

Nursing educators from across the country collaborated with industry leaders and learned the latest developments in nursing education at the 2010 Mosby's Faculty Development Institute conference earlier this month. Presented by Mosby, the three-day educational conference addressed challenges in the nursing industry from a variety of perspectives.

12 Jan 2010

Frimley Park Hospital NHS Foundation Trust implements Picis software solutions

Picis today announced that Frimley Park Hospital NHS Foundation Trust in Surrey, England has successfully implemented Picis integrated surgical, anesthesia, recovery room and critical care software solutions.

12 Jan 2010

FDA approves Celsius RMT ThermoCool catheter for use with Stereotaxis' magnetic navigation system

Stereotaxis announced that the Celsius® RMT ThermoCool® catheter has been approved by the U.S. Food and Drug Administration for use with Stereotaxis' magnetic navigation system for the treatment of Type 1 atrial flutter. The product is the fifth advanced ablation catheter resulting from the on-going co-development agreement between Stereotaxis and Biosense Webster to design and distribute magnetically enabled catheters for mapping and ablation.

12 Jan 2010

Cytheris commences enrollment in its recombinant human Interleukin-7 INSPIRE 2 program for HIV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).

12 Jan 2010

VentiRx Pharmaceuticals completes $25 million Series A Extension

VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today the completion of a $25 million Series A Extension.

12 Jan 2010

Astro Pak announces the launch of new subsidiary, SixLog

Astro Pak Corporation, the U.S.'s largest precision cleaning and passivation company, today announced the launch of their new subsidiary, SixLog Corporation. SixLog provides on-site biological decontamination services utilizing proprietary iHP™ (ionized Hydrogen Peroxide) technology to a variety of industries including Life Sciences, Pharmaceutical, Healthcare, First Responders, Transportation, and Public Facilities.

12 Jan 2010

ePro custom footbeds reduce sport-induced injuries

eSoles® Custom Footbeds, the world's leading authority in the science and development of custom footbeds, announced today that eSoles Pro, Karlos Dansby, linebacker for the Arizona Cardinals® (#58), lead his team to a victory during their NFC Wild-Card playoff game while wearing his eSoles custom footbeds.

12 Jan 2010

MedGenesis Therapeutix enters into license agreement with Amgen

MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.

12 Jan 2010

Madison Williams launches Healthcare Investment Banking and Research business

Madison Williams and Company, an integrated capital markets and advisory firm, announced today the formal launch of a focused Healthcare Investment Banking and Research business. Madison Williams recently completed a management buyout of the principal capital markets business from Sanders Morris Harris Group in December 2009. The new firm already has a leading franchise in the Energy sector, and is quickly establishing its presence in healthcare with key new hires.

12 Jan 2010

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

NanoViricides, Inc. (the "Company"), reports that the Company has been invited to present on January 12th at the Biotech Showcase™, a conference designed to showcase promising companies and technologies for partnering and investment purposes.

12 Jan 2010

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company’s increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.

12 Jan 2010

GeckoSystems' CEO issues 2009 year end open letter to stockholders

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that a 2009 year's end letter from their CEO can be viewed at their website, or Pinksheets.com.

12 Jan 2010

Public health and environment at risk: Large tobacco company influences EU policymaking

One of the world's largest tobacco companies has been instrumental in pushing through fundamental changes to EU policymaking, researchers from the University of Bath have found.

12 Jan 2010

Product quality becomes important to end users in sterilisation and disinfection equipment market

Due to the lack of adequate financing and weak healthcare infrastructure, price sensitivity within the Eastern European sterilisation and disinfection equipment market remains high.

12 Jan 2010

Market for chronic tophaceous gout medications will be led by drug that resolves tophi in less than a year

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the U.S. and Europe, a drug that resolves tophi in less than one year would become the patient share leader in the chronic tophaceous gout patient subpopulation and would be used in the vast majority of patients who suffer severe tophaceous gout, according to surveyed U.S. and European rheumatologists.

12 Jan 2010

Israeli Minister of Science and Technology visits BrainStorm Cell Therapeutics; reviews ALS clinical trials

BrainStorm Cell Therapeutics Inc.(OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that it received a visit yesterday by the Israeli Minister of Science and Technology, Professor Daniel Hershkowitz. The

12 Jan 2010

Experts to present latest research findings on reproductive medicine at ESHRE 26th annual meeting

Reproductive medicine is one of the most exciting scientific and clinical areas. Every month different announcements of research developments, medical 'firsts', new rulings by regulatory bodies, or ethical controversies are published and often spark a heated debate among practitioners in the field, as well as ethicists, legislators, the media and the public.

12 Jan 2010

Health Press NA releases new children’s bibliotherapy book on separation anxiety

Health Press NA Inc. (www.healthpress.com) releases a new children’s bibliotherapy book regarding separation anxiety. Bug Bites and Campfires: A Story for Kids About Homesickness addresses anxiety and homesickness in a delightful story about going away to camp.

12 Jan 2010

Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, if Pfizer/Medivation's Dimebon shows efficacy in two ongoing clinical trials in moderate to severe Alzheimer's disease that is equivalent to the impressive clinical trial data it has already shown to date in mild to moderate patients, these positive data would promote the use of Dimebon throughout the course of the disease.

12 Jan 2010

Medical News

Quantros' application for fulfilling complex reporting requirements of MMSEA Section 111

Nursing educators learn latest developments in nursing education at Faculty Development Institute conference

Frimley Park Hospital NHS Foundation Trust implements Picis software solutions

FDA approves Celsius RMT ThermoCool catheter for use with Stereotaxis' magnetic navigation system

Cytheris commences enrollment in its recombinant human Interleukin-7 INSPIRE 2 program for HIV

VentiRx Pharmaceuticals completes $25 million Series A Extension

Astro Pak announces the launch of new subsidiary, SixLog

ePro custom footbeds reduce sport-induced injuries

MedGenesis Therapeutix enters into license agreement with Amgen

Madison Williams launches Healthcare Investment Banking and Research business

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

GeckoSystems' CEO issues 2009 year end open letter to stockholders

Public health and environment at risk: Large tobacco company influences EU policymaking

Product quality becomes important to end users in sterilisation and disinfection equipment market

Market for chronic tophaceous gout medications will be led by drug that resolves tophi in less than a year

Israeli Minister of Science and Technology visits BrainStorm Cell Therapeutics; reviews ALS clinical trials

Experts to present latest research findings on reproductive medicine at ESHRE 26th annual meeting

Health Press NA releases new children’s bibliotherapy book on separation anxiety

Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News